KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced its membership in the Subcutaneous (SC) Drug Development & Delivery Consortium (the “Consor...
Source: pharmiweb.com